GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Deferred Policy Acquisition Costs

Nextbiomedical Co (XKRX:389650) Deferred Policy Acquisition Costs


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Nextbiomedical Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.